Search

Your search keyword '"Carrier, Lucie"' showing total 589 results

Search Constraints

Start Over You searched for: Author "Carrier, Lucie" Remove constraint Author: "Carrier, Lucie"
589 results on '"Carrier, Lucie"'

Search Results

1. Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy

2. Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy

4. Western diet triggers cardiac dysfunction in heterozygous Mybpc3-targeted knock-in mice: A two-hit model of hypertrophic cardiomyopathy

7. EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy

8. Reducing microtubule detyrosination improves heart function in HCM mice and human iPSC-engineered heart tissues

10. Abstract 12927: Impact of AAV-MYBPC3 Gene Transfer on Heart Structure and Function in Human and Mouse Models of Hypertrophic Cardiomyopathy

12. Modelling LMNA-cardiomyopathy with patient-specific human iPSC-derived engineered heart tissue and a partial rescue by gene replacement therapy

13. Functional characterisation of a patient-derived laminopathy model in human engineered heart tissues recapitulates fibrosis and mechanical decoupling defect

16. ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

17. Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

18. Cas9-expressing chickens and pigs as resources for genome editing in livestock

19. CMYA5 is a novel interaction partner of FHL2 in cardiac myocytes

20. Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics

21. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)

22. Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart

24. ACTN2mutant causes proteopathy in human iPSC-derived cardiomyocytes

25. Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy

27. Translational investigation of electrophysiology in hypertrophic cardiomyopathy

30. FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In Vivo

31. Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy

33. A high-throughput screening identifies ZNF418 as a novel regulator of the ubiquitin-proteasome system and autophagy-lysosomal pathway

34. Targets for therapy in sarcomeric cardiomyopathies

35. Nitro-fatty acids suppress ischemic ventricular arrhythmias by preserving calcium homeostasis

36. Depletion of Vasohibin 1 Speeds Contraction and Relaxation in Failing Human Cardiomyocytes

38. Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function

40. Investigation of ventricular arrhythmia mechanisms in hypertrophic cardiomyopathy in mice and men

43. Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue

44. Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

45. Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role ofTNNI3

Catalog

Books, media, physical & digital resources